Agile Therapeutics is a women's health specialty pharmaceutical company dedicated to developing and commercializing prescription contraceptive products. The company's core mission is to provide women with more healthcare choices through innovative contraceptive solutions. Their flagship product, Twirla, utilizes their proprietary SkinFusion® technology to enhance drug administration and wearability, addressing the needs of women seeking reliable and convenient birth control options.
Notable figures associated with Agile Therapeutics include its experienced leadership team and a board of directors with extensive backgrounds in pharmaceuticals and healthcare. The company has secured investments from prominent healthcare-focused venture capital firms, and its key achievements include the FDA approval of Twirla. Agile Therapeutics continues to impact the market by prioritizing women's health, and it now operates as an acquired subsidiary.
